Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Balance Sheet
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H's total assets for Q1 2026 were ¥17.01B, an increase of 2.29% from the previous quarter. HK:9989 total liabilities were ¥4.78B for the fiscal quarter, a 5.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.